ivWatch, LLC

ivWatch, LLC ivWatch, LLC is medical device and biosensor company looking to improve patient safety during IV use

ivWatch, LLC is a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy. IV therapy is a basic yet critical component of care in hospital and outpatient settings, but it has a high failure rate. Continuous monitors exist to keep track of patients’ heart, blood oxygen levels and pulse rates. Until now, no technology has been available to continuously monitor the health of a patient’s IV site, and whether drugs or fluids are being delivered through the vein or leaking into the tissue. The ivWatch Model 400 is a FDA-cleared device to help clinicians monitor the status of a patient’s IV to aid in the early detection of peripheral IV infiltrations and extravasations. Through the use of non-invasive sensor technology, the ivWatch Model 400 can help reduce potentially serious medication dosing errors and associated patient harm from infiltration events. A continuously monitored peripheral IV also offers an alternative to more intrusive vascular access devices when medically indicated. Use of these devices has increased, but can also pose significant risk of harm to patients and greater cost and liability for hospitals. ivWatch has the potential to transform IV therapy by improving patient care and safety, and offering health care providers a much-needed, reliable and cost-effective solution for continuously monitoring peripheral IVs.

ivWatch recognized a critical gap in IV therapy and created the only product that effectively tackles the widespread glo...
11/06/2025

ivWatch recognized a critical gap in IV therapy and created the only product that effectively tackles the widespread global problem of IV extravasation and infiltration.

Earlier this year, Wayne Shepherd joined the ivWatch team after over a decade in the vascular access field, bringing his passion and determination to advance safer IV therapy practices.

Calcium chloride can save a life in seconds—but if it extravasates, it can change a life forever. Our latest blog breaks...
11/05/2025

Calcium chloride can save a life in seconds—but if it extravasates, it can change a life forever.

Our latest blog breaks down why CaCl₂ is one of the most dangerous vesicants used in emergency care, how injuries progress from minutes to months, and why early detection is critical.

What you’ll learn:
• What makes calcium chloride extravasation so destructive
• How CaCl₂ injuries progress—from immediate pain to long-term damage
• Strategies to prevent extravasation, including continuous monitoring
• Training resources to strengthen infusion safety practices

This is essential reading for anyone involved in emergency medicine, critical care, infusion therapy, or vascular access.

Read the full article: https://www.ivwatch.com/2025/11/04/the-hidden-hazard-understanding-calcium-chloride-10-extravasation-and-its-risks/

Give your team the knowledge—and the tools—to prevent preventable injuries.

As a former bedside nurse, our clinical specialist Jackie knows firsthand the challenges of identifying an IV infiltrati...
10/31/2025

As a former bedside nurse, our clinical specialist Jackie knows firsthand the challenges of identifying an IV infiltration at the earliest stages before harm is already underway.

Jackie's dedication to educating and collaborating with clinicians, contributes to stronger patient care standards - helping to support nurses in making every peripheral IV safer.

Join the mission: https://www.ivwatch.com/

If your hospital doesn’t know its IV infiltration or extravasation rates, you’re not alone. Most organizations don’t tra...
10/22/2025

If your hospital doesn’t know its IV infiltration or extravasation rates, you’re not alone. Most organizations don’t track them—because they’re not required to.

But this data gap hides one of the most frequent sources of preventable harm in modern healthcare.

Here’s what the evidence shows—and how hospitals are closing the gap with continuous monitoring.

Read More: https://www.ivwatch.com/2025/10/21/when-routine-becomes-risk-rethinking-iv-safety-hospital-wide/

A preventable IV injury left baby Everly with permanent damage. While undergoing critical surgery in the NICU, Everly su...
10/16/2025

A preventable IV injury left baby Everly with permanent damage.

While undergoing critical surgery in the NICU, Everly suffered a severe IV infiltration that caused lasting harm to her tiny foot. Months later, her foot remained visibly swollen, raising questions about her ability to walk or even wear matching shoes in the future.

It didn’t have to happen.

IV infiltrations are common and often go unnoticed until the physical signs have caused severe injury. However, proactive hospitals choosing to implement continuous patient IV site monitoring as a standard of care are able to detect extravasations before physical signs are visible and preventing severe patient harm.

Read the latest third-party research: https://bmjopen.bmj.com/content/15/7/e094464

Sign up today: https://events.teams.microsoft.com/event/0c0515bd-7996-4f6a-a1e9-a0ee5e65a087@e4793c48-5702-4a04-a353-7a4...
10/14/2025

Sign up today: 0c0515bd-7996-4f6a-a1e9-a0ee5e65a087@e4793c48-5702-4a04-a353-7a4fc14d3f1c!" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/0c0515bd-7996-4f6a-a1e9-a0ee5e65a087@e4793c48-5702-4a04-a353-7a4fc14d3f1c!

Don’t miss this exclusive opportunity to hear from Roland VanRens, international thought leader in neonatal and vascular access.

He’ll be sharing evidence-based strategies on early recognition—and how they can significantly reduce IV harm, protect patients, and empower clinicians to transform outcomes.

In this week’s DeviceTalks podcast, Jaclyn Lautz, Ph.D. explains how ivWatch is transforming patient safety with real-ti...
10/13/2025

In this week’s DeviceTalks podcast, Jaclyn Lautz, Ph.D. explains how ivWatch is transforming patient safety with real-time monitoring of IV sites.

Current standard practice relies on nurses checking IVs manually every hour or few hours, often detecting issues after damage and an injury is progressing. ivWatch changes that by continuously monitoring the IV site, giving early alerts to staff before complications develop.

In today’s busy clinical environment, ivWatch provides an extra layer of safety, ensuring patients are protected and care is proactive.

⏩ Skip to minute 21 to hear Jaclyn share her insights firsthand!

Listen to the full podcast here: https://www.devicetalks.com/understanding-cognito-therapeutics-mission-to-bring-hope-to-people-families-enduring-dementia/

The ANCC Conference is underway with great energy and engagement for innovation implementation ideas. Looking for a solu...
10/09/2025

The ANCC Conference is underway with great energy and engagement for innovation implementation ideas. Looking for a solution with tangible results for quality improvement programs and patient safety initiatives?

Stop by Booth 1831 to see how ivWatch can strengthen your hospital’s Magnet program and elevate patient care. We’re excited to connect with nurses and leaders making a difference every day to prevent avoidable harm!

Mark your calendars now — this is a unique opportunity to hear firsthand insights from Roland VanRens, an international ...
10/06/2025

Mark your calendars now — this is a unique opportunity to hear firsthand insights from Roland VanRens, an international thought leader in neonatal and vascular access. He’ll share his latest research on early recognition and how it can dramatically reduce the severity of IV harm.

This is more than a webinar — it’s a moment to invest in your patients and yourself, gaining strategies that prevent harm and give clinicians the power to transform outcomes.

Join us LIVE: 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟭𝟲 | 𝟭𝟮 𝗣𝗠 𝗘𝗦𝗧

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: 0c0515bd-7996-4f6a-a1e9-a0ee5e65a087@e4793c48-5702-4a04-a353-7a4fc14d3f1c" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/0c0515bd-7996-4f6a-a1e9-a0ee5e65a087@e4793c48-5702-4a04-a353-7a4fc14d3f1c

Hospitals striving for Magnet recognition know that excellence is measured by quality improvement initiatives, evidence-...
10/03/2025

Hospitals striving for Magnet recognition know that excellence is measured by quality improvement initiatives, evidence-based practices, improved patient outcomes, and patient safety.

Implementing ivWatch can help you deliver on these categories. See for yourself at the ANCC Magnet Conference with American Nurses Association — visit booth 1831 to learn how continuous IV monitoring can strengthen your hospital’s Magnet program.

Risky patients and risky drugs: consider neonates due to their fragile veins, oncology patients receiving costly vesican...
10/01/2025

Risky patients and risky drugs: consider neonates due to their fragile veins, oncology patients receiving costly vesicants, or the ICU patient that is sedated and unable to speak — these patients are at the highest risk for extravasation injuries to occur.

Periodic IV assessments are simply not enough. An infiltration or extravasation injury can form in just a few drops of fluid.

See how continuous monitoring is redefining the standard of care to detect avoidable harm:
https://ivwatch.com/2025/09/30/high-stakes-higher-standards-the-case-for-continuous-monitoring-nicu-oncology-icu/

09/30/2025

On NICU Awareness Day, we’re reminded that every IV failure statistic represents a child’s story. As former CEO of Mercy Children's Kansas City, Paul Kempinski, MS, FACHE, CEC shares, nearly half of all IVs fail—and in neonatal care, the rates can climb as high as 70%. Behind every number is a newborn who may face pain or lasting injury that could have been prevented.

We believe this is a call to action to change mindsets and to change culture. We all have a responsibility to avoid preventable harm by elevating our IV safety standards. It’s time to challenge our teams, our tools, our protocols and share our commitment to protecting our most vulnerable patients so that we can intervene before harm occurs.

Join the movement.

Reference: https://lnkd.in/eDbfN7CM

Address

700 Tech Center Parkway, Suite 300
Newport News, VA
23606

Opening Hours

Monday 8:30am - 6pm
Tuesday 8:30am - 6pm
Wednesday 8:30am - 6pm
Thursday 8:30am - 6pm
Friday 8:30am - 6pm

Website

Alerts

Be the first to know and let us send you an email when ivWatch, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ivWatch, LLC:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

ivWatch, LLC is a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy. IV therapy is a basic yet critical component of care in hospital and outpatient settings, but it has a high failure rate. Continuous monitors exist to keep track of patients’ heart, blood oxygen levels and pulse rates. Until now, no technology has been available to continuously monitor the health of a patient’s IV site, and whether drugs or fluids are being delivered through the vein or leaking into the tissue. The ivWatch Model 400 is a FDA-cleared device to help clinicians monitor the status of a patient’s IV to aid in the early detection of peripheral IV infiltrations and extravasations. Through the use of non-invasive sensor technology, the ivWatch Model 400 can help reduce potentially serious medication dosing errors and associated patient harm from infiltration events. A continuously monitored peripheral IV also offers an alternative to more intrusive vascular access devices when medically indicated. Use of these devices has increased, but can also pose significant risk of harm to patients and greater cost and liability for hospitals. ivWatch has the potential to transform IV therapy by improving patient care and safety, and offering health care providers a much-needed, reliable and cost-effective solution for continuously monitoring peripheral IVs.